US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

ALLO Allogene Therapeutics Inc

2.86

0.10 (3.62%)

Fuera de horario

Última actualización: 16:59:00

Retrasado por 15 minutos

Swaap v2 Launches: Revolutionizing DeFi Market Making with Secure, Autopilot Strategies

Paris, France, July 10th, 2023, Chainwire Leveraging its successful $4.5m fundraising, Swaap launches its v2 protocol, bringing easy-to-use and powerful ... Read more
https://www.valuewalk.com/swaap-v2-launches-revolutionizing-defi-market-making-with-secure-autopilot-strategies/

Allogene Therapeutics (NASDAQ:ALLO)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Allogene Therapeutics.

Allogene Therapeutics (NASDAQ:ALLO)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Allogene Therapeutics.

Noticias sobre Allogene Therapeutics Inc ALLO

Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
Lunes 6 de Mayo 2024 (3 días hace) • GlobeNewswire Inc.

Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
Viernes 26 de Abril 2024 (2 semanas hace) • GlobeNewswire Inc.

Allogene Therapeutics Announces Q2 Investor Conference Participation
Martes 9 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
Jueves 14 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease
Martes 12 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
Martes 5 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference
Miércoles 28 de Febrero 2024 (2 meses hace) • GlobeNewswire Inc.

Form 8-K - Current report
Viernes 16 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia
Viernes 16 de Febrero 2024 (3 meses hace) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Miércoles 31 de Enero 2024 (3 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Miércoles 24 de Enero 2024 (3 meses hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunes 22 de Enero 2024 (4 meses hace) • Edgar (US Regulatory)

Más de Allogene Therapeutics Inc Artículos de Noticias

Invesco QQQ Trust Series 1

American Express

Health Care Select Sector

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones